InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
3
T+90 hit rate
57%
T+90 mean return
+2.5%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by ELMS STEVE, Director. Officer active across 4 companies, notably Marker Therapeutics, Inc.. Aggregated, 13 filings have been recorded. Split: 1 buy · 3 sells. Total volume traded: €4.9m. Activity tracked since 8 June 2021. The latest transaction was filed on 19 February 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations13 total
10,889 shares0Common StockSEC:0001140361-25-005541:0
11,085 shares@ US$3.20100.0% of flowCommon StockSEC:0001104659-24-131704:0
Ideal exit: 19 Sept 2025 (T+270)
9,000 shares@ US$10.801.9% of flowCommon StockSEC:0001140361-24-048224:0
49,887 shares@ US$6.015.5% of flowCommon StockSEC:0001140361-24-014226:0
411,829 shares@ US$6.0846.2% of flowCommon StockSEC:0001140361-24-014226:1
407,000 shares@ US$6.2146.4% of flowCommon StockSEC:0001140361-24-013634:0
24,040 shares0Common StockSEC:0001140361-24-010237:0
25,815 shares0Common StockSEC:0001140361-23-010771:0
26,586 shares0Common StockSEC:0001140361-22-008676:0
15,000 shares0Common StockSEC:0001567619-21-012087
15,000 shares0Common StockSEC:0001567619-21-012087:0
12,658 shares0Common StockSEC:0001209191-21-039632:0
12,658 shares0Common StockSEC:0001209191-21-039632
13 of 13 declarations
About ELMS STEVE
Steve Elms is a Director at Marker Therapeutics, Inc. and Zosano Pharma Corp. In this role, he participates in the governance of the company and strategic decision-making. His expertise in the biopharmaceutical sector is valuable in guiding research and development initiatives. As a director, he ensures that best practices are followed and that shareholder interests are protected.
